- •Assessment of the patient with cataract
- •Pre-operative biometry and intraocular lens calculation
- •Recent advances in intraocular lens technology
- •Techniques in cataract surgery
- •Management of the patient with cataract and astigmatism
- •Post-operative management following cataract surgery
- •Complications following cataract surgery
- •Paediatric cataract: aetiology, diagnosis and management
- •The future of cataract surgery management
- •Appendix 10.1
- •Appendix 10.2
- •Appendix 10.3
- •Appendix 10.4
- •Appendix 10.5
- •Appendix 10.6
- •Index
Index
A
Accommodative intraocular lens, 75–82
Accreditation assessment questions asked for, 222–224
Acetazolamide (Diamox), 127, 137, 176
side effects of, 127, 179 Acyclovir, 138 Against-the-rule (ATR), 109
astigmatism, 113 Ageing lens, 1–14
scatter and absorption changes, 36 Age-related macular degeneration
(ARMD), 21–22, 137, 174 Alcon ReStor lens, 78, 78f Amblyopia, 22
after paediatric cataract surgery, 199 paediatric cataracts, 203
Ametropia, 47, 166 Amino acid titres, 194 A-model transducer, 29 Anaesthesia
sub-Tenon’s, 93, 94f, 103 topical, 93
Analgesia, 127 Angina, 25 Anisometropia, 135
Anterior chamber, 129 Anterior polar cataracts, 12
Anterior subcapsular cataracts, 11
Antibiotics, topical
following cataract surgery, 133 Anti-inflammatory agents, topical
following cataract surgery, 132–133 Aphakia
paediatric cataracts, 200–202 clear visual axis, 200
Aphakic child
clear visual axis, 200 contact lenses, 201 optical correction, 200
ARMD see Age-related macular degeneration (ARMD)
Array lens, 80, 80f Artificial tears, 47
A-scan ultrasonography, 47–49 contact echogram, 54f, 56f, 58f dense lenticular opacities, 59–63 echogram interpretation, 51–53 immersion echogram, 55f, 56f
sloping retinal spike, 55f optical nerve misalignment, 55–59 posterior lens echogram, 64f probe perpendicularity, 53–54 sources for error, 49
visual axis alignment, 53
Aspheric intraocular lens, 83–84, 85f, 86f
Aspirin, 26 Astigmatism, 8, 107–125
against-the-rule, 36
Index
|
Astigmatism (Cont’d) |
Blepharitis, 24 |
232 |
ATR, 113 |
Blink reflex, 126 |
|
axis misalignment vs. residual, 112f |
BPH see Benign prostatic hypertrophy |
|
clinical impact, 112 |
(BPH) |
|
cornea, 85–86 |
B-scan ultrasonography, 27, 29 |
|
corneal topography vs. keratometry, |
C |
|
113 |
|
|
defined, 109 |
Capsular cataracts, 11 |
|
frequency, 112 |
Capsulorrhexis, 98f |
|
future developments, 122 |
Cardiff Acuity Test, 192f |
|
incisions, age and location, 116 |
Cataracts, see also individual cataracts |
|
induced, 167 |
assessment of, 17–32 |
|
irregular, 36 |
causes of, 2–3 |
|
laser, 122 |
classification of, 5–14 |
|
limbal relaxing and corneal relaxing |
definition of, 90 |
|
incisions, 115–118 |
effect on visual function, 18–19 |
|
marking steep meridian prior to |
formation of, 2 |
|
surgery, 113–114, 114f |
post-operative management, |
|
oblique, 109 |
125–140 |
|
oblique position, 112 |
referral service level agreement, |
|
on-axis incision, 115 |
219–221 |
|
preoperative assessment, 113 |
risk factors for, 2 |
|
pseudoaccommodative lenses, 77 |
Cataract surgery, 88–106, see also |
|
ray tracing, 109f |
Phacoemulsification cataract |
|
surgically induced, 110 |
surgery |
|
toric intraocular lens, 118–122 |
complications during, 139 |
|
combining toric IOL and incision |
complications following, 141–182 |
|
techniques, 122 |
capsule rupture, 104 |
|
with-the-rule, 36 |
choroidal haemorrhage or |
|
ATR see Against-the-rule (ATR) |
effusion, 105 |
|
Atropine, 197 |
corneal, 104 |
|
Axial length measurements, 39–40, 41–44 |
incidence of, 144–146 |
|
B |
indications of, 130 |
|
regional anaesthesia, 103 |
|
|
Bathing |
daily activities following, 132 |
|
following cataract surgery, 132 |
direct optometric referral and share |
|
Bell’s phenomenon, 126 |
care post-operatively, 210 |
|
Benign prostatic hypertrophy (BPH), 26 |
final review, 133–134 |
|
Bilateral nuclear opacities, 184 |
future of, 207–214 |
|
Bimanual phacoemulsification, 101 |
with glaucoma or vitreo-retinal |
|
Biometry, 27, 29, 34 |
surgery, 136 |
|
corneal compression, 51 |
iris trauma, 160f |
|
difficulties, 65 |
models of, 213 |
|
immersion, 51 |
patient expectations, 131 |
|
preoperative, 33–72 |
previous, 38 |
Index
Cataract surgery (Cont’d) |
abscess, 118 |
|
risks vs. benefits, 18 |
astigmatism, 85–86 |
233 |
selection for, 18–22 |
complications related to, 153–155 |
|
traditional model, 209–212 |
compression, biometric error, 49 |
|
training requirements for optometric |
diurnal variations in physiology, 36 |
|
direct referral, 211–212 |
endothelial decompensation with |
|
Centerflex toric intraocular lens, 119, |
persistent or severe oedema, 154 |
|
119f |
limbal tunnel incision, 96f |
|
Central, steady and maintained (CSM) |
mild edema, 153 |
|
system, 188 |
non-sphericity of, 37 |
|
Central cataracts, 188 |
oedema, 154 |
|
Cerulean cataracts, 14 |
pathology, 19 |
|
Chondroitin sulphate (Viscoat), 98 |
post-operative assessment, 130 |
|
Choose and Book, 213–214 |
power of, 34 |
|
Choroidal haemorrhage, 105 |
suture, 97f |
|
Christmas tree cataract, 8 |
thermal burns, 104 |
|
Chronic obstructive pulmonary |
topography, 27, 29 |
|
disease, 25 |
wound burn, 146 |
|
Closed suprachoroidal haemorrhage, |
Corneal relaxing incisions (CRI), 115 |
|
173 |
vs. LRI, 116 |
|
Coexisting ocular conditions |
Coronary cataracts, 13 |
|
predicting cataract surgery |
Cortical cataracts, 6 |
|
outcomes, 19 |
decreased contrast sensitivity, 7 |
|
Coexisting retinal disease progression, |
driving difficulties, 7 |
|
174 |
Cotyledons, 8 |
|
Community post-cataract operation |
Couching, 90 |
|
report form example, 228–230 |
Cover test |
|
Complete cataracts, 12 |
binocular alignment, 189f |
|
Confrontational visual field |
Craniofacial abnormalities, 185 |
|
examination, 24 |
CRI see Corneal relaxing incisions |
|
Congenital cataracts, 12–13 |
(CRI) |
|
morphological classification of, 12 |
Crystalens, 75, 75f, 82 |
|
Conjunctival chemosis, 150 |
CSM see Central, steady, and |
|
Conjunctival inclusion cysts, 104 |
maintained (CSM) system |
|
Conjunctivitis, 24 |
Cystoid macular oedema, 135, 169–170 |
|
Contact echogram, 54f, 56f, 58f |
Cytomegalic inclusion disease, 194 |
|
Contact lenses, 36–37 |
D |
|
aphakic child, 201 |
|
|
hydrogel, 202 |
Daycase surgery, 93, 93f |
|
rigid gas permeable, 202 |
DC see Dioptres of cylinder (DC) |
|
silicone, 201 |
Descemet detachment, 147 |
|
silicone hydrogel, 201 |
Descemet’s membrane, 104 |
|
Contact ultrasonography, 50f |
Dexamethasone |
|
Cornea, 138 |
following cataract surgery, 132–133 |
|
abrasion, 155 |
Diabetes, 25, 136 |
|
Index
|
Diabetic retinopathy, 20, 21 |
Echogram, 48 |
234 |
proliferative, 20 |
contact, 54f, 56f, 58f |
|
Diamox, 127, 137, 176 |
ideal immersion, 52f |
|
side effects of, 127, 179 |
immersion, 55f, 56f |
|
Diet |
interpretation, 51–53 |
|
following cataract surgery, 132 |
Electrolytes, 194 |
|
Diffraction |
Elschnig pearls, 76, 163 |
|
altering angle, 77 |
Emmetrope, 74, 131 |
|
grating, 77, 78f |
Endophthalmitis, 146, 156, 157f |
|
Diffractive lenses, 77 |
following cataract surgery, 133 |
|
Dilating eye drops, 197 |
following paediatric cataract surgery, |
|
Dioptres of cylinder (DC), 110 |
199 |
|
Diplopia, 180 |
Endothelial decompensation with |
|
Direct illumination |
persistent or severe corneal |
|
PSC, 9 |
oedema, 154 |
|
Direct ophthalmoscope |
Epikeratophakia, 201, 203 |
|
retinal red reflex, 187f |
Erbium:YAG laser, 101, see also Yttrium |
|
Directorate of Optometric Continuing |
aluminum, garnet (YAG) laser |
|
Education and Training |
Expulsive choroidal haemorrhage, |
|
(DOCET), 216 |
105 |
|
Direct referral form example, 225–226 |
Extracapsular cataract extraction |
|
Discharge instructions, 130–132 |
(ECCE), 100 |
|
Distance visual acuity, 27, 28 |
Extraocular movements, 180 |
|
Divide and conquer technique, 99, 100f |
Eye |
|
DOAS see Do Once and Share |
axial length of, 29, 34 |
|
(DOAS) |
cleaning, 133 |
|
DOCET see Directorate of |
pads/shields, 126 |
|
Optometric Continuing |
Eye drops |
|
Education and Training |
dilating, 197 |
|
(DOCET) |
Eyelid-related complications, 177 |
|
Do Once and Share (DOAS), 214 |
Eyepieces |
|
Down’s syndrome, 13 |
failure to focus on, 37 |
|
Driver and Vehicle Licensing Agency |
F |
|
(DVLA), 23 |
|
|
guidelines, 132 |
Fixation test, 10-PD, 188 |
|
Driving |
Flashing lights, 138 |
|
following cataract surgery, 132 |
Flomax, 26 |
|
Drug allergy, 178 |
Fluorescein, 129 |
|
Dry eyes, 24, 47 |
Fluorescein angiography, 170 |
|
DVLA see Driver and Vehicle Licensing |
Focusing on objects |
|
Agency (DVLA) guidelines |
PSC, 9 |
|
E |
Foldable intraocular lens, 102, 102f |
|
implants, 92–93 |
|
|
ECCE see Extracapsular cataract |
Fresnel prisms, 181 |
|
extraction (ECCE) |
Frisby test, 191, 192, 195f |
Index
Fuch’s dystrophy, 25 |
HPMC see Hydroxypropyl |
|
Fundus, 22 |
methylcellulose (HPMC) |
235 |
G |
Human Optics 1CU, 75, 76f |
|
Hydrodissection, 99f |
|
|
Galactokinase, 195 |
Hydrogel contact lenses, 202 |
|
Galactosemia, 185 |
Hydroxypropyl methylcellulose |
|
Gas permeable (GP) contact lenses, |
(HPMC), 98 |
|
202 |
Hypertension |
|
Genetics |
systemic, 25 |
|
paediatric cataracts, 195 |
Hyphaema, 151, 151f |
|
Glare |
I |
|
cortical cataracts, 7 |
|
|
from lens-edge effect with square- |
Ibuprofen, 127 |
|
profile IOLs, 168 |
Ideal immersion echogram, 52f |
|
PSC, 9 |
IFIS see Intraoperative floppy iris |
|
Glaucoma, 19, 137, 175–176 |
syndrome (IFIS) |
|
after cataract surgery, 136, 175 |
Immersion biometry |
|
after paediatric cataract surgery, 198 |
corneal compression, 51 |
|
narrow-angle, 23 |
Immersion echogram, 55f, 56f |
|
steroid-induced, 176 |
Immersion ultrasonography, 50, 50f |
|
Globe perforation, 103 |
Incomplete cataracts, 12 |
|
GP see Gas permeable (GP) contact |
Inflammatory reaction, 22–23 |
|
lenses |
Intracapsular cataract extraction, 90 |
|
Group 1 drivers, 23 |
Intraocular lens (IOL), 85, see also Toric |
|
Group 2 drivers, 23 |
intraocular lens |
|
H |
accommodative, 75–82 |
|
aspheric, 83–84, 85f, 86f |
|
|
Haemorrhage |
biometry, 68–70 |
|
choroidal, 105 |
calculations, 33–72, 68 |
|
closed suprachoroidal, 173 |
constants |
|
expulsive choroidal, 105 |
equations, 68t |
|
intraorbital, 103 |
values, 69 |
|
retrobulbar, 103 |
decentration, 160, 161f |
|
suprachoroidal, 174f |
design, 34 |
|
Haigis formula, 70 |
dioptric power, 34 |
|
Hallerman-Streiff syndrome, 185 |
efficacy, 74 |
|
Healon, 97–98 |
foldable, 92–93, 102, 102f |
|
Herpes simplex, 194 |
haptic prolapse, 161 |
|
Herpetic disease, 138 |
multifocal, 75–82 |
|
Hoffer Q, 70 |
styles, 81 |
|
Holladay 1, 70 |
natural, 87f |
|
Holladay 2, 70 |
post-operative assessment, 130 |
|
Hospital assessment |
power equations, 68–70 |
|
preoperative, 24 |
recent technological advances, |
|
medication, 26 |
73–88 |
|
Index
|
Intraocular lens (IOL) (Cont’d) |
Lens echogram |
236 |
secondary, 203 |
posterior, 64f |
|
spectacle independence, 83, 83f |
Light sensitivity, 131 |
|
Intraocular pressure |
Limbal relaxing incisions (LRI), 81, |
|
measuring, 192 |
115 |
|
post-operative spikes, 127, 130 |
advantages, 117 |
|
Intraoperative floppy iris syndrome |
contraindications, 117 |
|
(IFIS), 26 |
disadvantages, 117 |
|
Intraorbital haemorrhage, 103 |
LogMar visual acuity, 28, 28f |
|
IOL see Intraocular lens (IOL) |
Loss of vision |
|
IOLMaster, 29, 30f, 42f–44f, 45–46, 59, 65 |
cortical cataracts, 6 |
|
constants, 69 |
Lowe’s syndrome, 12, 185 |
|
equations, 69 |
LRI see Limbal relaxing incisions (LRI) |
|
practical advice, 45–46, 46f |
M |
|
Zeiss, 39–40, 40f, 53 |
|
|
IQ lens, 84–85 |
Macular oedema, 20–21, 136 |
|
Iris |
Mature cataracts, 10, 10f |
|
cataract surgery, 160f |
Medications |
|
defects, 159 |
following cataract surgery, 132–133 |
|
prolapse, 149 |
Membrane cataracts, 14 |
|
J |
Metabolic disorders, 2 |
|
Microperforation, 118 |
|
|
Juvenile cataracts, 12–13 |
Mixed cataracts, 10 |
|
K |
Modern extracapsular cataract |
|
extraction, 91 |
|
|
Kay Pictures Test, 193f |
Modified Fine-Thornton ring, 117 |
|
Keratometers, 29, 35–38 |
Modulation transfer function (MTF), 85 |
|
errors in, 36–38 |
Morgagnian cataracts, 10 |
|
improper calibration, 37 |
MTF see Modulation transfer function |
|
Ketorolac, 136 |
(MTF) |
|
following cataract surgery, 132–133 |
Multifocal implantation |
|
L |
patient selection, 82 |
|
visual results after, 83 |
|
|
Lamellar cataracts, 12, 13f |
Multifocal intraocular lens, 75–82 |
|
LASIK, 38 |
styles |
|
Lens |
pros and cons, 81 |
|
ageing, 1–14 |
Myopia, 8, 28 |
|
oxidation, 36 |
N |
|
scatter and absorption changes, |
|
|
36 |
Narrow-angle glaucoma, 23 |
|
with filters, 87 |
Nasolacrimal blockage, 24 |
|
function, 2 |
Natural intraocular lens, 87f |
|
growth, 3 |
Near visual acuity, 27, 28 |
|
surgical complications related to, |
Neurological disease, 22 |
|
160–165 |
New-onset floaters, 138 |
Index
Nuclear cataracts, 7–9, 13 |
comprehensive ocular examination, |
|
brightness acuity tester, 7f |
191–193 |
237 |
yellowing lens nuclei, 8f |
etiology of, 184 |
|
NuLens, 76–77 |
family education and social |
|
Number plate test, 23 |
circumstances, 204 |
|
O |
genetic consultations, 195 |
|
history, 186 |
|
|
Oblate, 84 |
investigations, 194 |
|
Oblique astigmatism, 109 |
management of, 196–204 |
|
OCT see Optical coherence |
morphology of, 185 |
|
tomography (OCT) |
neonates, 188 |
|
Ocular conditions, coexisting |
observation, 186 |
|
predicting cataract surgery |
ocular examination, 186–191 |
|
outcomes, 19 |
posterior capsule management, 200 |
|
Ocular movement examination, 194f |
primary or secondary IOL |
|
Ocular surface examination, 24 |
implantation, 200 |
|
Ocuscan RxP, 69 |
prognosis of, 196 |
|
OMP see Ophthalmic medical |
red reflex test, 186–187 |
|
practitioners (OMP) |
surgery |
|
Only eye patient, 22 |
complications, 198–199 |
|
Ophthalmic medical practitioners |
vs. conservative management, 197 |
|
(OMP), 221–222 |
timing, 197 |
|
Optical coherence tomography (OCT), |
type, 198 |
|
170 |
systemic examination, 192–193 |
|
Optical interferometer, 29 |
visual assessment, 188 |
|
Optic nerve disease, 22 |
visual significance, 196 |
|
Optometrists |
Pain, 127, 131 |
|
post-operative care, 212–213 |
Pan-retinal laser photocoagulation |
|
training packages for, 212 |
(PRP), 20 |
|
Optometry referral shared-care scheme |
Paracetamol, 127 |
|
Queen Victoria Hospital, Brighton, |
Partial cataracts, 12 |
|
215–218 |
Partial coherence interferometry, 39–40 |
|
Orbscan, 113 |
Patient letter example, 227 |
|
P |
PCCC see Posterior continuous |
|
curvilinear capsulorrhexis |
|
|
Paediatric cataracts, 188 |
(PCCC) |
|
aetiology, diagnosis, and |
PCO see Posterior capsular |
|
management, 183–204 |
opacification (PCO) |
|
amblyopia, 203 |
PD see Prism dioptre (PD) |
|
anterior polar and nuclear, 185–186 |
PDR see Proliferative diabetic |
|
aphakia, 200–202 |
retinopathy (PDR) |
|
clear visual axis, 200 |
Perfect Capsule, 76 |
|
bilateral, 185 |
Perkins tonometry, 192 |
|
clinical diagnosis of, 186–195 |
Persistent hyperplastic primary |
|
complications of, intraoperative, 198 |
vitreous (PHPV), 185 |
|
Index
|
Phaco-chop technique, 99, 100f |
Posterior subcapsular cataracts (PSC), |
238 |
Phacoemulsification cataract surgery, |
9–10, 9f |
|
27f, 92–101 |
Posterior vitreous detachment (PVD), |
|
bimanual, 101 |
138, 171 |
|
capsulorrhexis, 98 |
Post-operative care, 127–129, 212–213, |
|
corneal sutures, 96 |
215–218, 219–221 |
|
hydrodissection, 99 |
Post-operative management |
|
incision site, 95 |
cataracts, 125–140 |
|
instrumentation, 116 |
Prager shell, 50f, 51 |
|
intraocular lens implantation, |
Prednisolone acetate |
|
102 |
following cataract surgery, |
|
laser cataract surgery, 101 |
132–133 |
|
local anaesthesia, 93–94 |
PRELEX, 30 |
|
microincision, 101 |
Preoperative biometry, 33–72 |
|
small incision, 95 |
Preoperative hospital assessment, 24 |
|
viscoelastic, 97 |
medication, 26 |
|
Phenylephrine hydrochloride, 197 |
Preoperative investigations, 25 |
|
Phimosis |
Preoperative tests, 27–30 |
|
anterior capsule, 165 |
Presbyopia, 3, 31 |
|
Photophobia, 135 |
Preservative allergy, 178 |
|
PHPV see Persistent hyperplastic |
Prism dioptre (PD), 188 |
|
primary vitreous (PHPV) |
Prolate, 84 |
|
Physical activities |
Proliferative diabetic retinopathy |
|
following cataract surgery, 132 |
(PDR), 20 |
|
PMMA see Poly methyl methacrylate |
Prolonged diplopia, 103 |
|
(PMMA) |
Prolonged strabismus, 103 |
|
Polar cataracts, 11 |
PRP see Pan-retinal laser |
|
Poly methyl methacrylate (PMMA), 77, |
photocoagulation (PRP) |
|
92 |
PSC see Posterior subcapsular |
|
Post-cataract operation report form |
cataracts (PSC) |
|
example |
Pseudoaccommodative lenses, 77–81 |
|
community, 228–230 |
astigmatism, 77 |
|
Posterior capsular opacification (PCO), |
Pseudoexfoliation, 19, 19f, 25 |
|
162–163, 163f |
Ptosis, 177 |
|
after paediatric cataract surgery, 199 |
Pupil |
|
Posterior capsular rupture, 139 |
post-operative assessment, 130 |
|
Posterior cataracts, 188 |
reflexes, 192 |
|
Posterior continuous curvilinear |
PVD see Posterior vitreous |
|
capsulorrhexis (PCCC), 121 |
detachment (PVD) |
|
Posterior lens echogram, 64f |
Q |
|
Posterior polar cataracts, 11f, 12 |
|
|
Posterior segment complications, |
Quality of life, 18 |
|
169–174 |
Queen Victoria Hospital, Brighton |
|
Posterior staphyloma |
shared-care scheme for direct |
|
biometry, 65 |
optometry, 215–218 |
Index
Questions asked for accreditation |
Service level agreement |
|
assessment, 222–224 |
for combined direct cataract |
239 |
R |
referral, 219–221 |
|
Severe glare disability |
|
|
Redness, 131 |
cortical cataracts, 7 |
|
Red reflex test, 187f |
Shared-care scheme |
|
paediatric cataracts, 186–187 |
for direct optometry referral, 215–218 |
|
Refraction, 27 |
Showering |
|
Refractive changes and stability |
following cataract surgery, 132 |
|
after cataract surgery, 135 |
SIA see Surgically induced astigmatism |
|
Refractive complications, 166–168 |
(SIA) |
|
Refractive error, 35 |
Silicone contact lenses, 201 |
|
Refractive lenses, 79–80 |
Silicone hydrogel contact lenses, 201 |
|
Refractive lens exchange (RLE), 82 |
Silicone oil, 65 |
|
Regional anesthesia |
Slit lamp examination, 24, 192 |
|
complications of, 103 |
Snellen acuity, 188 |
|
Regression formulae, 68 |
Snellen measurements, 28 |
|
Relative afferent pupillary defect, 24 |
Sodium hyaluronate (Healon), 97–98 |
|
ReStor lenses, 79, 81, 82 |
Spectacles |
|
energy distribution for, 79f |
children, 202 |
|
Retained lens matter, 164 |
free vision for all distances, 108 |
|
Retina, 138 |
Specular microscopy, 27 |
|
Retinal disease progression |
SRK I and II, 69 |
|
coexisting, 174 |
SRK-T, 70 |
|
Retinal tear or detachment, 172 |
Stellate cataracts, 13 |
|
Retinal vascular disorders, 22 |
Steroids, topical |
|
Retrobulbar haemorrhage, 103 |
following cataract surgery, 132–133 |
|
Retrodots, 11 |
Strabismus |
|
Return to work |
after paediatric cataract surgery, 199 |
|
following cataract surgery, 132 |
Sub-Tenon’s anaesthesia, 93, 94f |
|
ReZoom lens, 81, 82 |
complications of, 103 |
|
Rigid gas permeable (GP) contact |
Suprachoroidal haemorrhage, 174f |
|
lenses, 202 |
Surgically induced astigmatism (SIA), |
|
RLE see Refractive lens exchange (RLE) |
110 |
|
Royal College of Ophthalmologists |
Suture irritation, 148 |
|
guidelines, 18, 25, 69, 70t |
Sutureless extracapsular cataract |
|
Rubella, 194 |
extraction (SECCE), 91, 92f |
|
S |
Swimming |
|
following cataract surgery, 132 |
|
|
SECCE see Sutureless extracapsular |
Syphilis, 194 |
|
cataract extraction (SECCE) |
Systemic hypertension, 25 |
|
Secondary intraocular lens |
T |
|
implantation, 201, 203 |
|
|
Second-eye surgery, 135, 136 |
Target refraction |
|
Seidel test, 129, 129f, 143, 146, 152 |
biometry, 66–67 |
|
Index
|
Tear film |
Urgent cataract surgery, 22 |
240 |
inadequate, 37–38 |
Urine test, 194 |
|
Tecnis Z900 lens, 84 |
User Group for Laser Interference |
|
Telephone assessment, 128 |
Biometry (ULIB), 69 |
|
Theoretical formulae, 68 |
Uveal complications, 156–159 |
|
Titmus Fly test, 191 |
Uveitis, 19, 136 |
|
Tonopen, 192 |
persistent, 157 |
|
Topical anaesthesia, 93 |
recurrent, 158 |
|
Topical antibiotics |
V |
|
following cataract surgery, 133 |
|
|
Topical anti-inflammatory agents |
Valvular heart disease, 25 |
|
following cataract surgery, |
VDRL titre, 194 |
|
132–133 |
VEP see Visual evoked potential (VEP) |
|
Topical steroids |
Vertical diplopia, 103–104 |
|
following cataract surgery, |
Vertical prism, 10-D, 190f |
|
132–133 |
Viscoat, 98 |
|
TORCHS tire screen (toxoplasmosis, |
Vision |
|
rubella, cytomegalic inclusion |
improvement in, 131 |
|
disease, herpes simplex, and |
loss of |
|
syphilis ), 194 |
cortical cataracts, 6 |
|
Toric intraocular lens, 85–86, 118–122 |
Visual acuity testing, 193f |
|
advantages and disadvantages, |
Visual driving standards, 23–24 |
|
122 |
Visual evoked potential (VEP), 188 |
|
astigmatism, 118–122 |
Visual field examination |
|
combining toric IOL and incision |
confrontational, 24 |
|
techniques, 122 |
Vitreo-retinal surgery |
|
biometry, 120 |
cataract surgery, 136 |
|
Centerflex, 119, 119f |
Vitreous opacification, 20 |
|
C-flex platform, 87 |
Vitreous wick, 152 |
|
ideal, 119 |
W |
|
post-operative assessment, 122 |
|
|
SN60 single-piece lens, 87 |
Warfarin, 25–26 |
|
Total cataracts, 12, 188 |
Watering, 131 |
|
Toxoplasmosis, 194 |
Weiss’ ring floating anterior to optic |
|
Traumatic cataracts, 14 |
disc, 171f |
|
Tropicamide, 197 |
With-the-rule (WTR), 109, 110f |
|
U |
Work |
|
return to following cataract surgery, |
|
|
ULIB see User Group for Laser |
132 |
|
Interference Biometry (ULIB) |
Wound, 129 |
|
Ultrasonography, see also A-scan |
complications related to, 143–152 |
|
ultrasonography |
leak, 143–145 |
|
B-scan, 27, 29 |
after paediatric cataract surgery, |
|
contact, 50f |
199 |
|
immersion, 50, 50f |
WTR see With-the-rule (WTR) |
Index
Y |
Z |
|
Yttrium aluminum, garnet (YAG) laser, |
Zeiss IOLMaster, 39–40, 40f, 53 |
241 |
101, 119, 200 |
Zonular cataracts, 12 |
|
capsulotomy, 164, 165, 166 vitreolysis, 153
